177 related articles for article (PubMed ID: 15747065)
1. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
Hämmerlein A; Weiske J; Huber O
Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
[TBL] [Abstract][Full Text] [Related]
2. Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1.
Aoki M; Hecht A; Kruse U; Kemler R; Vogt PK
Proc Natl Acad Sci U S A; 1999 Jan; 96(1):139-44. PubMed ID: 9874785
[TBL] [Abstract][Full Text] [Related]
3. A noncanonical sequence phosphorylated by casein kinase 1 in beta-catenin may play a role in casein kinase 1 targeting of important signaling proteins.
Marin O; Bustos VH; Cesaro L; Meggio F; Pagano MA; Antonelli M; Allende CC; Pinna LA; Allende JE
Proc Natl Acad Sci U S A; 2003 Sep; 100(18):10193-200. PubMed ID: 12925738
[TBL] [Abstract][Full Text] [Related]
4. Casein kinase 2 (CK2) increases survivin expression via enhanced beta-catenin-T cell factor/lymphoid enhancer binding factor-dependent transcription.
Tapia JC; Torres VA; Rodriguez DA; Leyton L; Quest AF
Proc Natl Acad Sci U S A; 2006 Oct; 103(41):15079-84. PubMed ID: 17005722
[TBL] [Abstract][Full Text] [Related]
5. Coordinated action of CK1 isoforms in canonical Wnt signaling.
Del Valle-Pérez B; Arqués O; Vinyoles M; de Herreros AG; Duñach M
Mol Cell Biol; 2011 Jul; 31(14):2877-88. PubMed ID: 21606194
[TBL] [Abstract][Full Text] [Related]
6. A functional screen in human cells identifies UBF2 as an RNA polymerase II transcription factor that enhances the beta-catenin signaling pathway.
Grueneberg DA; Pablo L; Hu KQ; August P; Weng Z; Papkoff J
Mol Cell Biol; 2003 Jun; 23(11):3936-50. PubMed ID: 12748295
[TBL] [Abstract][Full Text] [Related]
7. beta-Arrestin1 modulates lymphoid enhancer factor transcriptional activity through interaction with phosphorylated dishevelled proteins.
Chen W; Hu LA; Semenov MV; Yanagawa S; Kikuchi A; Lefkowitz RJ; Miller WE
Proc Natl Acad Sci U S A; 2001 Dec; 98(26):14889-94. PubMed ID: 11742073
[TBL] [Abstract][Full Text] [Related]
8. T-cell factor 4N (TCF-4N), a novel isoform of mouse TCF-4, synergizes with beta-catenin to coactivate C/EBPalpha and steroidogenic factor 1 transcription factors.
Kennell JA; O'Leary EE; Gummow BM; Hammer GD; MacDougald OA
Mol Cell Biol; 2003 Aug; 23(15):5366-75. PubMed ID: 12861022
[TBL] [Abstract][Full Text] [Related]
9. Presenilin 1 negatively regulates beta-catenin/T cell factor/lymphoid enhancer factor-1 signaling independently of beta-amyloid precursor protein and notch processing.
Soriano S; Kang DE; Fu M; Pestell R; Chevallier N; Zheng H; Koo EH
J Cell Biol; 2001 Feb; 152(4):785-94. PubMed ID: 11266469
[TBL] [Abstract][Full Text] [Related]
10. Nr-CAM is a target gene of the beta-catenin/LEF-1 pathway in melanoma and colon cancer and its expression enhances motility and confers tumorigenesis.
Conacci-Sorrell ME; Ben-Yedidia T; Shtutman M; Feinstein E; Einat P; Ben-Ze'ev A
Genes Dev; 2002 Aug; 16(16):2058-72. PubMed ID: 12183361
[TBL] [Abstract][Full Text] [Related]
11. Interaction between Smad7 and beta-catenin: importance for transforming growth factor beta-induced apoptosis.
Edlund S; Lee SY; Grimsby S; Zhang S; Aspenström P; Heldin CH; Landström M
Mol Cell Biol; 2005 Feb; 25(4):1475-88. PubMed ID: 15684397
[TBL] [Abstract][Full Text] [Related]
12. Synergistic coactivator function by coactivator-associated arginine methyltransferase (CARM) 1 and beta-catenin with two different classes of DNA-binding transcriptional activators.
Koh SS; Li H; Lee YH; Widelitz RB; Chuong CM; Stallcup MR
J Biol Chem; 2002 Jul; 277(29):26031-5. PubMed ID: 11983685
[TBL] [Abstract][Full Text] [Related]
13. The Molecular Basis of Wnt/
Anand AA; Khan M; V M; Kar D
Int J Cell Biol; 2023; 2023():9296092. PubMed ID: 37780577
[TBL] [Abstract][Full Text] [Related]
14. Reconstitution of the destruction complex defines roles of AXIN polymers and APC in β-catenin capture, phosphorylation, and ubiquitylation.
Ranes M; Zaleska M; Sakalas S; Knight R; Guettler S
Mol Cell; 2021 Aug; 81(16):3246-3261.e11. PubMed ID: 34352208
[TBL] [Abstract][Full Text] [Related]
15. FAT4 overexpression promotes antitumor immunity by regulating the β-catenin/STT3/PD-L1 axis in cervical cancer.
Wang D; Wu S; He J; Sun L; Zhu H; Zhang Y; Liu S; Duan X; Wang Y; Xu T
J Exp Clin Cancer Res; 2023 Sep; 42(1):222. PubMed ID: 37658376
[TBL] [Abstract][Full Text] [Related]
16. A small molecule inhibitor of beta-catenin/CREB-binding protein transcription [corrected].
Emami KH; Nguyen C; Ma H; Kim DH; Jeong KW; Eguchi M; Moon RT; Teo JL; Kim HY; Moon SH; Ha JR; Kahn M
Proc Natl Acad Sci U S A; 2004 Aug; 101(34):12682-7. PubMed ID: 15314234
[TBL] [Abstract][Full Text] [Related]
17. Loss of presenilin 1 is associated with enhanced beta-catenin signaling and skin tumorigenesis.
Xia X; Qian S; Soriano S; Wu Y; Fletcher AM; Wang XJ; Koo EH; Wu X; Zheng H
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10863-8. PubMed ID: 11517342
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of WNT signaling by G protein-coupled receptor (GPCR) kinase 2 (GRK2).
Wang L; Gesty-Palmer D; Fields TA; Spurney RF
Mol Endocrinol; 2009 Sep; 23(9):1455-65. PubMed ID: 19556343
[TBL] [Abstract][Full Text] [Related]
19. Rac1 augments Wnt signaling by stimulating β-catenin-lymphoid enhancer factor-1 complex assembly independent of β-catenin nuclear import.
Jamieson C; Lui C; Brocardo MG; Martino-Echarri E; Henderson BR
J Cell Sci; 2015 Nov; 128(21):3933-46. PubMed ID: 26403202
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of nuclear Wnt signalling: challenges of an elusive target for cancer therapy.
Lyou Y; Habowski AN; Chen GT; Waterman ML
Br J Pharmacol; 2017 Dec; 174(24):4589-4599. PubMed ID: 28752891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]